Cargando…
Impact of the Acceptance of the Recommendations Made by a Meropenem Stewardship Program in a University Hospital: A Pilot Study
Antimicrobial stewardship programs (ASP) promote appropriate antimicrobial use. We present a 4-year retrospective study that evaluated the clinical impact of the acceptance of the recommendations made by a meropenem-focused ASP. A total of 318 meropenem audits were performed. The ASP team (comprisin...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944864/ https://www.ncbi.nlm.nih.gov/pubmed/35326793 http://dx.doi.org/10.3390/antibiotics11030330 |
_version_ | 1784673822739267584 |
---|---|
author | Alba Fernandez, Jorge del Pozo, Jose Luis Leiva, Jose Fernandez-Alonso, Mirian Aquerreta, Irene Aldaz, Azucena Blanco, Andres Yuste, Jose Ramón |
author_facet | Alba Fernandez, Jorge del Pozo, Jose Luis Leiva, Jose Fernandez-Alonso, Mirian Aquerreta, Irene Aldaz, Azucena Blanco, Andres Yuste, Jose Ramón |
author_sort | Alba Fernandez, Jorge |
collection | PubMed |
description | Antimicrobial stewardship programs (ASP) promote appropriate antimicrobial use. We present a 4-year retrospective study that evaluated the clinical impact of the acceptance of the recommendations made by a meropenem-focused ASP. A total of 318 meropenem audits were performed. The ASP team (comprising infectious disease physicians, pharmacists and microbiologists) considered meropenem use in 96 audits (30.2%) to be inappropriate. The reasons to consider these uses inappropriate were the possibility of de-escalating to a narrower-spectrum antibiotic, in 66 (68.7%) audits, and unnecessary meropenem use, in 30 (31.3%) audits. The ASP team recommended de-escalation in 66 audits (68.7%) and discontinuation of meropenem in 30 audits (31.3%). ASP interventions were stratified according to whether or not recommendations were followed. The group in which recommendations were accepted and followed (i.e., accepted audit, AA) included 66 audits (68.7%) and the group in which recommendations were not followed (i.e., rejected audit, RA) included 30 (31.3%) audits. The comorbidity of the AA group (Charlson score) was higher than in the RA group (7.0 (5.0–9.0) vs. 6.0 (4.0–7.0), p = 0.02). Discontinuation of meropenem was recommended in 83.3% of audits in the AA group vs. 62.2% in the RA group (OR 3.05 (1.03–8.99), p = 0.04). Ertapenem de-escalation resulted in a 100% greater rate of follow-up compared with the non-carbapenem option (100% vs. 51.9%, OR 1.50 (1.21–1.860), p = 0.001). Significant differences were observed in the AA group when cultures were taken before antibiotic prescription—98.5% vs. 83.3% (p = 0.01, OR 13.0 (1.45–116.86))—or when screening cultures were taken—45.5% vs. 19.2% (p = 0.03, OR 3.5 (1.06–11.52)). There were no differences between the groups in terms of overall mortality and 30-day mortality, length of stay, Clostridiodes difficile infection, 30-day readmission or hospitalization costs. In conclusion, meropenem ASP recommendations contributed to a decrease in meropenem prescription without worsening clinical and economic outcomes. |
format | Online Article Text |
id | pubmed-8944864 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-89448642022-03-25 Impact of the Acceptance of the Recommendations Made by a Meropenem Stewardship Program in a University Hospital: A Pilot Study Alba Fernandez, Jorge del Pozo, Jose Luis Leiva, Jose Fernandez-Alonso, Mirian Aquerreta, Irene Aldaz, Azucena Blanco, Andres Yuste, Jose Ramón Antibiotics (Basel) Article Antimicrobial stewardship programs (ASP) promote appropriate antimicrobial use. We present a 4-year retrospective study that evaluated the clinical impact of the acceptance of the recommendations made by a meropenem-focused ASP. A total of 318 meropenem audits were performed. The ASP team (comprising infectious disease physicians, pharmacists and microbiologists) considered meropenem use in 96 audits (30.2%) to be inappropriate. The reasons to consider these uses inappropriate were the possibility of de-escalating to a narrower-spectrum antibiotic, in 66 (68.7%) audits, and unnecessary meropenem use, in 30 (31.3%) audits. The ASP team recommended de-escalation in 66 audits (68.7%) and discontinuation of meropenem in 30 audits (31.3%). ASP interventions were stratified according to whether or not recommendations were followed. The group in which recommendations were accepted and followed (i.e., accepted audit, AA) included 66 audits (68.7%) and the group in which recommendations were not followed (i.e., rejected audit, RA) included 30 (31.3%) audits. The comorbidity of the AA group (Charlson score) was higher than in the RA group (7.0 (5.0–9.0) vs. 6.0 (4.0–7.0), p = 0.02). Discontinuation of meropenem was recommended in 83.3% of audits in the AA group vs. 62.2% in the RA group (OR 3.05 (1.03–8.99), p = 0.04). Ertapenem de-escalation resulted in a 100% greater rate of follow-up compared with the non-carbapenem option (100% vs. 51.9%, OR 1.50 (1.21–1.860), p = 0.001). Significant differences were observed in the AA group when cultures were taken before antibiotic prescription—98.5% vs. 83.3% (p = 0.01, OR 13.0 (1.45–116.86))—or when screening cultures were taken—45.5% vs. 19.2% (p = 0.03, OR 3.5 (1.06–11.52)). There were no differences between the groups in terms of overall mortality and 30-day mortality, length of stay, Clostridiodes difficile infection, 30-day readmission or hospitalization costs. In conclusion, meropenem ASP recommendations contributed to a decrease in meropenem prescription without worsening clinical and economic outcomes. MDPI 2022-03-02 /pmc/articles/PMC8944864/ /pubmed/35326793 http://dx.doi.org/10.3390/antibiotics11030330 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Alba Fernandez, Jorge del Pozo, Jose Luis Leiva, Jose Fernandez-Alonso, Mirian Aquerreta, Irene Aldaz, Azucena Blanco, Andres Yuste, Jose Ramón Impact of the Acceptance of the Recommendations Made by a Meropenem Stewardship Program in a University Hospital: A Pilot Study |
title | Impact of the Acceptance of the Recommendations Made by a Meropenem Stewardship Program in a University Hospital: A Pilot Study |
title_full | Impact of the Acceptance of the Recommendations Made by a Meropenem Stewardship Program in a University Hospital: A Pilot Study |
title_fullStr | Impact of the Acceptance of the Recommendations Made by a Meropenem Stewardship Program in a University Hospital: A Pilot Study |
title_full_unstemmed | Impact of the Acceptance of the Recommendations Made by a Meropenem Stewardship Program in a University Hospital: A Pilot Study |
title_short | Impact of the Acceptance of the Recommendations Made by a Meropenem Stewardship Program in a University Hospital: A Pilot Study |
title_sort | impact of the acceptance of the recommendations made by a meropenem stewardship program in a university hospital: a pilot study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944864/ https://www.ncbi.nlm.nih.gov/pubmed/35326793 http://dx.doi.org/10.3390/antibiotics11030330 |
work_keys_str_mv | AT albafernandezjorge impactoftheacceptanceoftherecommendationsmadebyameropenemstewardshipprograminauniversityhospitalapilotstudy AT delpozojoseluis impactoftheacceptanceoftherecommendationsmadebyameropenemstewardshipprograminauniversityhospitalapilotstudy AT leivajose impactoftheacceptanceoftherecommendationsmadebyameropenemstewardshipprograminauniversityhospitalapilotstudy AT fernandezalonsomirian impactoftheacceptanceoftherecommendationsmadebyameropenemstewardshipprograminauniversityhospitalapilotstudy AT aquerretairene impactoftheacceptanceoftherecommendationsmadebyameropenemstewardshipprograminauniversityhospitalapilotstudy AT aldazazucena impactoftheacceptanceoftherecommendationsmadebyameropenemstewardshipprograminauniversityhospitalapilotstudy AT blancoandres impactoftheacceptanceoftherecommendationsmadebyameropenemstewardshipprograminauniversityhospitalapilotstudy AT yustejoseramon impactoftheacceptanceoftherecommendationsmadebyameropenemstewardshipprograminauniversityhospitalapilotstudy |